Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000145791 | SCV000192928 | likely benign | not specified | 2015-04-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000987080 | SCV000429412 | likely benign | D-2-hydroxyglutaric aciduria 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Center for Pediatric Genomic Medicine, |
RCV000444247 | SCV000510958 | likely benign | not provided | 2016-07-07 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Institute for Genomic Medicine |
RCV000145791 | SCV000864338 | likely benign | not specified | 2017-07-17 | criteria provided, single submitter | clinical testing | BS1, BP6; This alteration has an allele frequency that is greater than expected for the associated disease, and was reported as a benign/likely benign alteration by a reputable source (ClinVar or other correspondence from a clinical testing laboratory). |
Labcorp Genetics |
RCV000987080 | SCV001107582 | benign | D-2-hydroxyglutaric aciduria 1 | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000987080 | SCV001136278 | benign | D-2-hydroxyglutaric aciduria 1 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000444247 | SCV001153393 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | D2HGDH: BS2 |
Prevention |
RCV003917442 | SCV004737297 | benign | D2HGDH-related disorder | 2019-04-15 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Mayo Clinic Laboratories, |
RCV000444247 | SCV000802845 | uncertain significance | not provided | 2016-02-23 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000444247 | SCV001931583 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000444247 | SCV001966728 | likely benign | not provided | no assertion criteria provided | clinical testing |